Annals of Clinical and Translational NeurologyNeurosciencePeer-reviewed journal article
Developmental, neuroanatomical and cellular expression of genes causing dystonia
Darren CameroniD, Nicholas E. CliftoniD, Daniel Cabezas de la FuenteiD, Peter HolmansiD, Nicholas J. BrayiD, Kathryn J. PealliD
Abstract
ObjectiveDystonia is one of the most common forms of movement disorder with >50 genes identified as causative. However, an understanding of which developmental stages, brain regions and cell types are most relevant is crucial for developing relevant disease models and therapeutics. One approach is to examine the timing and anatomical expression of dystonia-causing genes, on the assumption that deleterious variants have a greater impact where higher levels of expression are observed. MethodsWe investigated the expression patterns of 44 dystonia-causing genes across two bulk- and two single-nuclei RNA-sequencing datasets, derived from prenatal and postnatal human brain tissue. ResultsDystonia genes were most strongly enriched in those with higher expression in the striatum, cerebral cortex, hippocampus, amygdala and substantia nigra, and for higher postnatal expression. Individual genes exhibiting differences in expression across adult brain regions include SQSTM1, SGCE, KMT2B, PRKRA, YY1, DNAJC12, KCNA1, CACNA1A (highest expression in cerebellum), ADCY5, GNAL, ANO3 (highest expression in striatum), RHOBTB2, FOXG1 (highest expression in cerebral cortex). Single-nuclei RNA-sequencing data analyses from human frontal cortex, striatum and cerebellum indicated that dystonia genes are predominantly expressed in neurons (both glutamatergic and GABAergic), rather than glia. Gene Ontology analysis showed prominent enrichment in biological processes such as dopamine biosynthetic and metabolic processes, and in the cellular components axons, presynapse and neuron projection. InterpretationThese analyses provide important insights into the anatomical, developmental and cellular expression patterns of dystonia-causing genes, potentially guiding the development of disease-relevant models and improving the timing and targeting of future therapeutic interventions.
- organism: human
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 41th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptomic analysis of dystonia-associated genes reveals functional convergence within specific cell types and shared neurobiology with psychiatric disorders
Niccolò Emanuele Mencacci, Regina Hertfelder Reynolds, … Caleb Webber·BrainPeer-reviewed·Jun 17, 2020
- Transcriptome profiles in brains of mice heterozygous for a DYT1 dystonia-associated mutation in the endogenous Tor1a gene
Sara B. Mitchell, Michael S. Chimenti, … Nobutoshi C. Harata·bioRxiv·Oct 31, 2019
- Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders
Maria A. Briscione, Ashok Reddy Dinasarapu, … Ellen J. Hess·bioRxiv·Jan 12, 2021
- Perisynaptic matrix gene variants underlie DystoniaGeneNet endophenotypes in isolated focal dystonia
Aloysius Domingo, Dongren Yao, … Laurie J. Ozelius·medRxiv·Oct 21, 2026
- A comprehensive spatiotemporal map of dystrophin isoform expression in the developing and adult human brain
Francesco Catapano, Reem R. Alkharji, … Francesco Muntoni A·Acta Neuropathologica CommunicationsPeer-reviewed·May 21, 2025
- Striatal cell-type-specific molecular signatures reveal therapeutic targets in a model of dystonia
Kaitlyn M. Roman, Ashok Reddy Dinasarapu, … Ellen J. Hess·bioRxiv·Oct 7, 2024